Intellia Therapeutics Inc buy SVB Leerink LLC
Start price
03.03.26
/
50%
€12.16
Target price
03.03.27
€24.79
Performance (%)
-3.54%
Price
19:09
€11.73
Summary
This prediction is currently active. With a performance of -3.54%, the BUY prediction by SVB_Leerink_LLC is trending in the wrong direction. This prediction currently runs until 03.03.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Intellia Therapeutics Inc | -0.404% |
| iShares Core DAX® | 0.751% |
| iShares Nasdaq 100 | -1.405% |
| iShares Nikkei 225® | 0.417% |
| iShares S&P 500 | -0.590% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its price target raised by Leerink Partners from $27.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat